Clinical Trials Logo

Clinical Trial Summary

The primary objective of this study is to assess the comparative gastrointestinal (GI) tolerance of normal term infants to two experimental powdered formulas compared with a commercially available powdered formula.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01155414
Study type Interventional
Source Abbott Nutrition
Contact
Status Completed
Phase Phase 3
Start date March 2010
Completion date July 2010

See also
  Status Clinical Trial Phase
Completed NCT02646969 - Growth and Metabolic Biomarkers of Healthy Term Infants Fed Formulas With Staged Protein Concentrations Over the First Year of Life N/A
Terminated NCT01137877 - Growth and Tolerance of Healthy Term Infants to a New Infant Formula Phase 3
Completed NCT04015050 - Randomised, Controlled Study to Assess Safety and Tolerance of Infant Formula With Prebiotics and Postbiotics in Healthy Infants. N/A
Completed NCT01497314 - Growth and Safety of a Low Lactose Milk-Based Infant Formula N/A
Terminated NCT02221687 - The Combiotic-Study N/A
Completed NCT00712608 - The Evaluation of Cow's Milk Formula - Study B N/A